Serra López-Matencio, J.M.; Gómez, M.; Vicente-Rabaneda, E.F.; González-Gay, M.A.; Ancochea, J.; Castañeda, S.
Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic. Pharmaceuticals 2021, 14, 819.
https://doi.org/10.3390/ph14080819
AMA Style
Serra López-Matencio JM, Gómez M, Vicente-Rabaneda EF, González-Gay MA, Ancochea J, Castañeda S.
Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic. Pharmaceuticals. 2021; 14(8):819.
https://doi.org/10.3390/ph14080819
Chicago/Turabian Style
Serra López-Matencio, José M., Manuel Gómez, Esther F. Vicente-Rabaneda, Miguel A. González-Gay, Julio Ancochea, and Santos Castañeda.
2021. "Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic" Pharmaceuticals 14, no. 8: 819.
https://doi.org/10.3390/ph14080819
APA Style
Serra López-Matencio, J. M., Gómez, M., Vicente-Rabaneda, E. F., González-Gay, M. A., Ancochea, J., & Castañeda, S.
(2021). Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic. Pharmaceuticals, 14(8), 819.
https://doi.org/10.3390/ph14080819